Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CDER Asked To Shed More Light On Potential Monograph User Fees

This article was originally published in The Pink Sheet Daily

Executive Summary

While Director Janet Woodcock and other CDER officials explain the center's reasons for proposing a monograph program user fee, some stakeholders suggest the agency explain more about how the program would work.

Advertisement

Related Content

Bayer Links OTC User Fees To Exclusivity, Hisamitsu Pans General Concept
OTC Monograph User Fees: FDA-Industry Talks Move From Basics To Details
PCPC: Cosmetic Legislation A Long Shot In 2016, But Objectives Are Clear

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel